Health-related Quality of Life of Patients With Esophageal Cancer After Surgery
Conditions
Esophageal Cancer
Conditions: official terms
Esophageal Neoplasms
Conditions: Keywords
health-related quality of life(HRQL), Esophageal Cancer
Study Type
Interventional
Study Phase
Phase 2
Study Design
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Intervention
Name: MIE Type: Procedure
Name: Three-incision thoracotomy Type: Procedure
Name: Ivor-Lewis esophagectomy Type: Procedure
Name: Sweet esophagectomy Type: Procedure
Overall Status
Not yet recruiting
Summary
The purpose of this multi-center prospective cohort study is to study the health-related quality of life (HRQL) together with other outcomes of patients with esophageal cancer after surgery in China.
Detailed Description
- To study the influence of health-related quality of life of patients with esophageal cancer before and after surgery.

- To compare the impact of different procedures on the the health-related quality of life of patients with esophageal cancer.

- To compare morbidities and oncological results(3,5- year survival) from different procedures.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 70 Years
Minimum Age: 35 Years
Gender: Both
Criteria: Inclusion Criteria:

- Clinical stage I/II esophageal cancer

- Normal blood test of basic metabolism panel

- Pulmonary function: FEV1 > 1.2L, FEV1% > 50%, DLCO > 50%

- Heart function: NY grade I and grade II

Exclusion Criteria:

- Mental disorders

- Combination with other cancers

- With a previous history of thoracic or ventral surgery
Location
Zhong Shan Hospital, Fu Dan University
Shanghai, Shanghai, China
Status: Not yet recruiting
Contact: Lijie Tan, MD - 86-021-64041990 - tan.lijie@zs-hospital.sh.cn
Start Date
May 2011
Completion Date
December 2016
Sponsors
Fudan University
Source
Fudan University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page